BCG Revaccination for the Prevention of <i>Mycobacterium tuberculosis</i> Infection
BCG revaccination in QFT-test negative, HIV-negative adolescents did not provide protection from sustained <i>M. tuberculosis</i> infection. (Funded by the Gates Foundation; ClinicalTrials.gov number NCT04152161.).
Authors
- Mark Hatherill (ORCID: https://orcid.org/0000-0003-3491-1809)
- Alexander C. Schmidt (ORCID: https://orcid.org/0000-0002-9226-3638)
- Gonasagrie Nair (ORCID: https://orcid.org/0000-0001-9005-2442)
- Elisa Nemes (ORCID: https://orcid.org/0000-0003-1662-4961)
- Angelique Luabeya Kany Kany
- Nicole Frahm (ORCID: https://orcid.org/0000-0003-1298-3676)
- Keren Middelkoop (ORCID: https://orcid.org/0000-0001-9922-4263)
- Ahu ÇINAR (ORCID: https://orcid.org/0000-0001-7095-1192)
- Thomas J. Scriba (ORCID: https://orcid.org/0000-0002-0641-1359)
- Michael W. Dunne (ORCID: https://orcid.org/0000-0001-6186-5196)
- Kogieleum Naidoo (ORCID: https://orcid.org/0000-0002-8874-6661)
- Robin Mogg
- Anele Gela (ORCID: https://orcid.org/0000-0003-1473-9204)
- Elizabeth Hellström
- David R. Kaufman (ORCID: https://orcid.org/0000-0001-9968-9968)
- Lee Fairlie (ORCID: https://orcid.org/0000-0001-5327-1734)
Institutions
- South African Medical Research Council (ZA)
- Gates (United States) (US)
- Desmond Tutu HIV Foundation (ZA)
- University of Cape Town (ZA)
- University of the Witwatersrand (ZA)
- Centre for the AIDS Programme of Research in South Africa (ZA)
- South African Tuberculosis Vaccine Initiative (ZA)
Publication Details
- Journal
- New England Journal of Medicine
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1056/nejmoa2412381
- Citations
- 30
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 41.89